Top compounds associated with response to GTF3C6


Feature Type Standardized
Nominal ANOVA
mRNA Axitinib CTRPv2 pan-cancer AAC 0.19 3e-08
mRNA linifanib CTRPv2 pan-cancer AAC 0.19 7e-08
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 8e-08
mRNA BI-2536 CTRPv2 pan-cancer AAC 0.17 1e-07
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 1e-07
mRNA Gemcitabine CTRPv2 pan-cancer AAC 0.17 2e-07
mRNA 3-Cl-AHPC CTRPv2 pan-cancer AAC 0.18 2e-07
mRNA Methotrexate CTRPv2 pan-cancer AAC 0.19 4e-07
mRNA regorafenib CTRPv2 pan-cancer AAC 0.19 5e-07
mRNA Ki8751 CTRPv2 pan-cancer AAC 0.18 7e-07
Download CSV